Virax Biolabs (VRAX) Inventory Average (2022 - 2025)

Virax Biolabs (VRAX) posted quarterly Inventory Average of $109965.0 for Q1 2025, up 18.47% quarter-over-quarter from $92819.0 in Q3 2024.

Virax Biolabs (VRAX) Inventory Average (2022 - 2025) Analysis & Trends

Virax Biolabs' Inventory Average history runs 3 years deep, the most recent figure standing at $109965.0 for Q1 2025.

In Q1 2025, Inventory Average changed N/A year-over-year to $109965.0; the TTM figure through Mar 2025 stood at $109965.0 (changed N/A YoY), while the FY2025 annual figure was $77529.0, changed N/A from the prior year.
Inventory Average for Q1 2025 stood at $109965.0, up from $92819.0 in the prior quarter.
The five-year high for Inventory Average was $109965.0 in Q1 2025, with the low at $21011.5 in Q1 2022.
The 3-year median for Inventory Average is $92819.0 (2024), against an average of $74598.5.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	90.57 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	137.65 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	196.36 Mn
10	Virax Biolabs	1.39 Mn	-5.05 Mn	-	-

Download Data